+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diabetes Drugs Market Research Reports

From
Type 1 Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Type 1 Diabetes - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Diabetic Neuropathy- Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Neuropathy- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Type 2 Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Trulicity - Global Strategic Business Report - Product Thumbnail Image

Trulicity - Global Strategic Business Report

  • Report
  • September 2025
  • 471 Pages
  • Global
From
Sulfonylureas - Global Strategic Business Report - Product Thumbnail Image

Sulfonylureas - Global Strategic Business Report

  • Report
  • September 2025
  • 362 Pages
  • Global
From
From
Glucagon-Like Peptide 1 Agonists - Global Strategic Business Report - Product Thumbnail Image

Glucagon-Like Peptide 1 Agonists - Global Strategic Business Report

  • Report
  • September 2025
  • 375 Pages
  • Global
From
Pediatric Diabetes Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pediatric Diabetes Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 464 Pages
  • Global
From
SGLT2 Inhibitors - Global Strategic Business Report - Product Thumbnail Image

SGLT2 Inhibitors - Global Strategic Business Report

  • Report
  • September 2025
  • 177 Pages
  • Global
From
Liraglutide and Semaglutide - Global Strategic Business Report - Product Thumbnail Image

Liraglutide and Semaglutide - Global Strategic Business Report

  • Report
  • September 2025
  • 451 Pages
  • Global
From
From
DPP-IV Inhibitors - Global Strategic Business Report - Product Thumbnail Image

DPP-IV Inhibitors - Global Strategic Business Report

  • Report
  • September 2025
  • 262 Pages
  • Global
From
From
From
Dementia With Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Dementia With Diabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Loading Indicator

The Diabetes Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat diabetes. Diabetes is a chronic condition that affects millions of people worldwide, and the drugs used to treat it can help to manage the symptoms and reduce the risk of complications. Commonly prescribed diabetes drugs include insulin, sulfonylureas, meglitinides, thiazolidinediones, and DPP-4 inhibitors. These drugs are used to help regulate blood sugar levels, reduce insulin resistance, and improve the body's ability to use insulin. Some of the major companies in the Diabetes Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the research, development, and marketing of diabetes drugs, and they are constantly striving to develop new and improved treatments for the condition. Show Less Read more